Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Fundación Castellano Leonesa de Hematología y Hemoterapia (FCLHH) is a Spanish non-profit organization dedicated to the advancement of hematology and hemotherapy in the Castile and León region. It serves as a central hub for clinical research, professional training, and the promotion of scientific excellence in treating blood-related disorders. The foundation collaborates closely with regional hospitals and universities to sponsor clinical trials and manage research projects focused on hematological malignancies and transfusion medicine. Its activities include organizing scientific congresses, providing grants for specialized training, and facilitating the implementation of innovative therapies like CAR-T cells within the regional health system. FCLHH plays a critical role in coordinating multi-center studies and ensuring that patients in the region have access to cutting-edge hematological treatments. By bridging the gap between academic research and clinical practice, the foundation enhances the quality of care for patients with leukemia, lymphoma, and other blood diseases.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Fundación Castellano Leonesa de Hematología y Hemoterapia.